Metraipolis › archive › dc_3ecaca2cbc4f
Nanomedicine-based cancer immunotherapy: translational barriers, mechanistic strategies, and future perspectives — Europe PMC PMID:42204786
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42204786
- DOI
- 10.1080/10717544.2026.2679846
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T05:59:24.986Z
- SHA-256 of the archived text
1a7dfa0af0dca093e5f6a1a7cab9fab68a1421cf0bc0c0036da50f180b1c55b1- Stable URL of this page
https://metraipolis.com/documento/dc_3ecaca2cbc4f
How to cite
Nanomedicine-based cancer immunotherapy: translational barriers, mechanistic strategies, and future perspectives — Europe PMC PMID:42204786 — Europe PMC (en), https://europepmc.org/article/MED/42204786 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3ecaca2cbc4f (Metraipolis archive dc_3ecaca2cbc4f, sha256 1a7dfa0af0dca093e5f6a1a7cab9fab68a1421cf0bc0c0036da50f180b1c55b1)
BibTeX
@misc{dc3ecaca2cbc4f,
title = {Nanomedicine-based cancer immunotherapy: translational barriers, mechanistic strategies, and future perspectives — Europe PMC PMID:42204786},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42204786},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3ecaca2cbc4f; sha256 1a7dfa0af0dca093e5f6a1a7cab9fab68a1421cf0bc0c0036da50f180b1c55b1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42204786. Agents can read the archived copy with the MCP tool read_document.